Prostate cancer: What does the future hold?
Friday 21 October 2016, Royal Society of Medicine
1 Wimpole Street
This meeting is intended to provide an educational state-of-the-art review of the very latest advances in the diagnosis and treatment of the commonest cancer to afflict men.
There will be presentations on all radical treatment options, including robotic surgery, radiotherapy and high intensity focused ultrasound (HIFU). The final session will focus on the management of more advanced disease with presentations on abiraterone, enzalutamide and the ground-breaking STAMPEDE study.
Day | Registration: 08:30 | Organised by: Urology Section |
Region: London | Accreditation: CPD - Applied for Find out more